{
    "clinical_study": {
        "@rank": "35145", 
        "arm_group": [
            {
                "arm_group_label": "Normal pregnancy", 
                "arm_group_type": "Other", 
                "description": "women pregnant"
            }, 
            {
                "arm_group_label": "pregnancy complicated by pre-eclampsia", 
                "arm_group_type": "Other", 
                "description": "women with pregnancy complicated by pre-eclampsia"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to explore a mechanism that could potentially explain why women\n      with a pregnancy complicated by pre-eclampsia are described as having an increased risk of\n      cardiovascular disease later in life.\n\n      If the hypothesis of this study turns out to be true, that is to say that women with\n      pre-eclampsia have a higher level of oxidative stress than women with a normal pregnancy and\n      that this difference persists after the delivery (6 months), a controlled randomized\n      interventional study aiming to evaluate either therapeutic supplementation with antioxidant\n      vitamins (Vit C and E) or modifications in diet could be envisaged."
        }, 
        "brief_title": "Circulating Oxidative Stress and Gestational Hypertension. Study of the Evolution of Free-radical Markers of Oxidative Stress From Before to After Childbirth in Two Groups of Women: Normal Pregnancy and Pre-eclampsia.", 
        "completion_date": {
            "#text": "November 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Pregnancy Complicated by Pre-eclampsia.", 
            "Normal Pregnancy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Eclampsia", 
                "Pre-Eclampsia", 
                "Hypertension, Pregnancy-Induced"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who have provided written informed consent\n\n          -  Patients covered by a Health Insurance scheme\n\n          -  Age > 18 years\n\n          -  Normal pregnancy\n\n          -  or pre-eclampsia defined according to the following classical criteria: (i) de novo\n             hypertension defined by arterial blood pressure of at least 140 mm Hg (systolic) or\n             at least 90 mm Hg (diastolic) confirmed by at least two measurements separated by at\n             least 4-6 h, occurring after the 20th week of gestation in a women known beforehand\n             to have a normal blood pressure, (ii) proteinuria defined by urinary excretion of at\n             least 300 mg of protein per 24 h. If 24-hour urine is not available, proteinuria is\n             defined as a concentration of urinary protein of 300 mg/L or more (or >1 + on the\n             urinary dip) in at least two samples of urine taken randomly, but at an interval of\n             at least 4-6 h [7]. Pre-eclampsia is defined as severe if: persistent systolic BP >\n             170 mm Hg and/or diastolic BP > 110 mm Hg, and/or diuresis < 30 ml/hour, and/or at\n             least 2 of the following signs (headache, phosphenes, epigastric pain or vomiting,\n             pyramidal-type patellar reflexes, papilledema, hepatic pain, thrombopenia < 100x106\n             /l, ALT AST > 70 UI/l and or hemolysis manifesting as haptoglobin < 0.06 g/l, or a\n             fall in LDH or the presence of schistocytes, the latter three signs define the HELLP\n             syndrome) and/or seizures.\n\n          -  Term> 26 SA.\n\n        Exclusion Criteria:\n\n          -  Refusal to provide consent\n\n          -  Context of patent infection.\n\n          -  Premature rupture of the fetal membranes.\n\n          -  preexisting or gestational diabetes.\n\n          -  Vasculoplacental diseases other than pre-eclampsia: placental abruption or\n             infarction, intrauterine growth retardation of in utero fetal death not occurring in\n             a context of pre-eclampsia.\n\n          -  Chronic or gestational AHT not meeting the criteria for pre-eclampsia.\n\n          -  Twin/multiple pregnancies"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01907620", 
            "org_study_id": "Sagot PHRC IR 2007"
        }, 
        "intervention": {
            "arm_group_label": [
                "Normal pregnancy", 
                "pregnancy complicated by pre-eclampsia"
            ], 
            "intervention_name": "blood sample", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Dijon", 
                    "country": "France", 
                    "zip": "21079"
                }, 
                "name": "CHU de Dijon"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "quantification of radical species", 
            "safety_issue": "No", 
            "time_frame": "baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01907620"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Universitaire Dijon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire Dijon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2010", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}